105 related articles for article (PubMed ID: 21309808)
21. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages.
Guruvayoorappan C; Kuttan G
Innate Immun; 2008 Jun; 14(3):160-74. PubMed ID: 18562575
[TBL] [Abstract][Full Text] [Related]
22. Thalidomide attenuates mammary cancer associated-inflammation, angiogenesis and tumor growth in mice.
Maria de Souza C; Fonseca de Carvalho L; da Silva Vieira T; Cândida Araújo E Silva A; Teresa Paz Lopes M; Alves Neves Diniz Ferreira M; Passos Andrade S; Dantas Cassali G
Biomed Pharmacother; 2012 Oct; 66(7):491-8. PubMed ID: 22705333
[TBL] [Abstract][Full Text] [Related]
23. Impaired inflammatory angiogenesis, but not leukocyte influx, in mice lacking TNFR1.
Barcelos LS; Talvani A; Teixeira AS; Vieira LQ; Cassali GD; Andrade SP; Teixeira MM
J Leukoc Biol; 2005 Aug; 78(2):352-8. PubMed ID: 15894588
[TBL] [Abstract][Full Text] [Related]
24. Fluvastatin downregulates VEGF-A expression in TNF-α-induced retinal vessel tortuosity.
Robinson R; Ho CE; Tan QS; Luu CD; Moe KT; Cheung CY; Wong TY; Barathi VA
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7423-31. PubMed ID: 21862649
[TBL] [Abstract][Full Text] [Related]
25. Short-term effects of fluvastatin therapy on plasma interleukin-10 levels in patients with chronic heart failure.
Tekin A; Sezgin N; Katircibaşi MT; Tekin G; Cölkesen Y; Sezgin AT; Müderrisoğlu H
Coron Artery Dis; 2008 Nov; 19(7):513-9. PubMed ID: 18923248
[TBL] [Abstract][Full Text] [Related]
26. Fluvastatin stabilizes the blood-brain barrier in vitro by nitric oxide-dependent dephosphorylation of myosin light chains.
Kuhlmann CR; Lessmann V; Luhmann HJ
Neuropharmacology; 2006 Sep; 51(4):907-13. PubMed ID: 16872642
[TBL] [Abstract][Full Text] [Related]
27. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
Haruna Y; Morita Y; Yada T; Satoh M; Fox DA; Kashihara N
Arthritis Rheum; 2007 Jun; 56(6):1827-35. PubMed ID: 17530711
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice.
Riad A; Bien S; Westermann D; Becher PM; Loya K; Landmesser U; Kroemer HK; Schultheiss HP; Tschöpe C
Cancer Res; 2009 Jan; 69(2):695-9. PubMed ID: 19147586
[TBL] [Abstract][Full Text] [Related]
29. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).
Ferreira MA; Barcelos LS; Teixeira MM; Bakhle YS; Andrade SP
Life Sci; 2007 Jun; 81(3):210-7. PubMed ID: 17588613
[TBL] [Abstract][Full Text] [Related]
30. Brazilian green propolis modulates inflammation, angiogenesis and fibrogenesis in intraperitoneal implant in mice.
Lima LD; Andrade SP; Campos PP; Barcelos LS; Soriani FM; Moura SA; Ferreira MA
BMC Complement Altern Med; 2014 May; 14():177. PubMed ID: 24886376
[TBL] [Abstract][Full Text] [Related]
31. Lovastatin and fluvastatin reduce viremia and the pro-inflammatory cytokines in the patients with chronic hepatitis C.
Mihăilă R; Nedelcu L; Frăţilă O; Rezi EC; Domnariu C; Ciucă R; Zaharie AV; Olteanu A; Bera L; Deac M; Mihăilă R
Hepatogastroenterology; 2009; 56(96):1704-9. PubMed ID: 20214221
[TBL] [Abstract][Full Text] [Related]
32. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
[TBL] [Abstract][Full Text] [Related]
33. The statins fluvastatin and pravastatin exert anti-flushing effects by improving vasomotor dysfunction through nitric oxide-mediated mechanisms in ovariectomized animals.
Shuto H; Tominaga K; Yamauchi A; Ikeda M; Kusaba K; Mitsunaga D; Hirabara Y; Egawa T; Takano Y; Kataoka Y
Eur J Pharmacol; 2011 Jan; 651(1-3):234-9. PubMed ID: 21114974
[TBL] [Abstract][Full Text] [Related]
34. Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells.
Potena L; Frascaroli G; Grigioni F; Lazzarotto T; Magnani G; Tomasi L; Coccolo F; Gabrielli L; Magelli C; Landini MP; Branzi A
Circulation; 2004 Feb; 109(4):532-6. PubMed ID: 14744969
[TBL] [Abstract][Full Text] [Related]
35. The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure.
Gürgün C; Ildizli M; Yavuzgil O; Sin A; Apaydin A; Cinar C; Kültürsay H
Int J Cardiol; 2008 Jan; 123(2):102-7. PubMed ID: 17320212
[TBL] [Abstract][Full Text] [Related]
36. Costunolide suppresses an inflammatory angiogenic response in a subcutaneous murine sponge model.
Saraswati S; Alhaider AA; Abdelgadir AM
APMIS; 2018 Mar; 126(3):257-266. PubMed ID: 29484750
[TBL] [Abstract][Full Text] [Related]
37. Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway.
Hu YF; Chen YC; Cheng CC; Higa S; Chen YJ; Chen SA
J Cardiovasc Electrophysiol; 2009 Feb; 20(2):200-6. PubMed ID: 18775044
[TBL] [Abstract][Full Text] [Related]
38. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
[TBL] [Abstract][Full Text] [Related]
39. Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules.
Mueck AO; Seeger H; Wallwiener D
Exp Clin Endocrinol Diabetes; 2001; 109(3):181-3. PubMed ID: 11409302
[TBL] [Abstract][Full Text] [Related]
40. The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome.
Yang J; Li XP; Zhao SP; Li J; Li JD; Xie XM
Clin Chim Acta; 2006 Jun; 368(1-2):183-7. PubMed ID: 16472797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
